Protagonist Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Protagonist Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protagonist Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Protagonist Therapeutics by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.9M | 83k | 22.93 |
| 2023-09-30 | $1.4M | 83k | 16.68 |
| 2023-06-30 | $2.2M | 78k | 27.62 |
| 2023-03-31 | $1.7M | 75k | 23.00 |
| 2022-12-31 | $776k | 71k | 10.91 |
| 2022-09-30 | $594k | 71k | 8.42 |
| 2022-06-30 | $527k | 67k | 7.92 |
| 2022-03-31 | $1.1M | 46k | 23.67 |
| 2021-12-31 | $1.5M | 44k | 34.21 |
| 2021-09-30 | $757k | 43k | 17.73 |
| 2021-06-30 | $1.8M | 41k | 44.89 |
| 2021-03-31 | $860k | 33k | 25.89 |
| 2020-12-31 | $680k | 34k | 20.16 |
| 2020-09-30 | $576k | 29k | 19.56 |
| 2020-06-30 | $524k | 30k | 17.66 |
| 2020-03-31 | $118k | 17k | 7.08 |
| 2019-12-31 | $115k | 16k | 7.06 |
| 2019-09-30 | $187k | 16k | 12.03 |
| 2019-06-30 | $156k | 13k | 12.11 |
| 2018-03-31 | $88k | 10k | 8.55 |
| 2017-09-30 | $178k | 10k | 17.63 |
| 2017-06-30 | $114k | 10k | 11.31 |